Screener
BioCryst Pharmaceuticals BCRX Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | 260 | — | (1,202) | — |
| Total other expense, net | (18,991) | (23,300) | (38,201) | (43,769) |
| Income (loss) before income taxes | 79,474 | 6,486 | (641,334) | 7,244 |
| Income tax expense | 1,079 | 1,401 | 2,083 | 2,127 |
| Net income (loss) | $78,395 | $5,085 | $(643,417) | $5,117 |
| Other comprehensive (loss) income: | ||||
| Foreign currency translation adjustment | (27) | 702 | (89) | 1,068 |
| Unrealized loss on available for sale investments | (133) | (188) | (477) | (343) |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's income tax?
- BioCryst Pharmaceuticals (BCRX) reported income tax of $1.08M in Q2 2026.
- How has BioCryst Pharmaceuticals's income tax changed year-over-year?
- BioCryst Pharmaceuticals's income tax decreased by 23.0% year-over-year, from $1.4M to $1.08M.
- What is the long-term trend for BioCryst Pharmaceuticals's income tax?
- Over 3 years (2021 to 2025), BioCryst Pharmaceuticals's income tax has grown at a 16.1% compound annual growth rate (CAGR), from $2.25M to $3.53M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about BioCryst Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude